chartexchange

IMCR
Immunocore Holdings plc
stockNASDAQADR

At CloseNov 18, 2026 3:59:58 PM EST
27.51USD-1.079%(-0.30)296,510
After-hoursNov 18, 2026 4:00:30 PM EST
27.51USD0.000%(-0.00)
Loading…
Loading…
Healthcare
Biotechnology
HQ
Abingdon, United Kingdom
Previous Close
$27.81
Beta
0.65
52-Week High
$40.71 2025-12-05
52-Week Low
$27.31 2026-11-17
SMA 50
$30.63
SMA 200
$31.51
Avg. Vol 10D
524,138
Avg. Vol 30D
511,083
Avg. Vol 90D
455,441
Relative Vol
0.58
46.02M
0.3300%
1,400,000
219
IMCR Profile

immunocore is a privately owned biotechnology company developing innovative biological therapeutics for the treatment of a range of serious diseases. its world-leading t cell receptor technology exploits the power of the body's own immune system to find and kill diseased cells. immunocore has established a robust technology platform which combines monoclonal t cell receptor (mtcr) targeting technology with an effector technology, anti-cd3 scfv, that catalyses the killing of the targeted diseased cells by the host's own non-specific cytotoxic t cells. immunocore is developing a portfolio of products from the platform, called immtacs, for the treatment of cancer, chronic infectious disease and diabetes.

IMCR Performance
PeriodPriceDateChangeBeta
1W30.482026-11-12-9.63%1.452
1M29.842026-10-19-7.71%0.947
3M36.862026-08-19-25.29%0.863
6M28.932026-05-19-4.80%0.538
1Y38.652025-11-19-28.75%0.654
2Y32.562024-11-19-15.42%—
5Y38.102021-11-19-27.72%0.777
IMCR Stock Summary

Immunocore Holdings plc (NASDAQ:IMCR) stock price today is $27.54, and today's volume is 296,510. IMCR is down 0.971% today. The 30 day average volume is 511,083. IMCR market cap is $1.42B with 51.68M shares outstanding.